Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 1074

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 1074
---
None.

Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not
applicable.

PART
III

Item
10. Directors, Executive Officers and Corporate Governance.

Our
directors and executive officers and their ages as of the date of this Report are as follows:

    Name
     
    Age
     
    Position
  
    Erez
    Aminov
     
    47
     
    Chief
    Executive Officer and Chairman
  
    Michelle
    Yanez
     
    53
     
    Chief
    Financial Officer, Secretary and Treasurer
  
    Matthew
    Pratt Whalen
     
    45
     
    Director
  
    Matthew
    Paul Del Giudice, M.D.
     
    43
     
    Director
  
    Denil
    Nanji Shekhat, M.D.
     
    44
     
    Director
  
    Edward
    MacPherson
     
    36
     
    Director

The
following is a brief biography of each of our current executive officers and directors:

Erez
Aminov has served as a director and our Chief Executive Officer since April 2023 and our Chairman since March 2024. Mr. Aminov
is an experienced biotechnology consultant and investor and initially joined our as a consultant in 2022. Mr. Aminov’s experience
in the biotech consulting sector began in 2021 when he founded Locate Venture Corp. in September 2021. Locate Venture is a strategy and
investment consulting firm focused on advancing and supporting early-stage biotech startups. Prior to founding Locate Venture Corp.,
from February 2015 to September 2020, Mr. Aminov served as the President of Finds4less Inc., a global distributor of electronics and
gaming products. In this role, Mr. Aminov provided strategic oversight and direction for all aspects of the company’s operations,
while also spearheading new business development initiatives to capitalize on emerging market opportunities. Mr. Aminov’s more
than two decades of experience includes experience with the biotech industry’s particular challenges, including creating strategic
alliances and guiding startups toward growth and prosperity. Mr. Aminov earned a B.A. in Accounting from Touro University in New York.
We believe that Mr. Aminov is qualified to serve as one of our directors based on his finance and investment experience, particularly
with early stage life sciences companies